Author:
Wang Tracy Y.,Hasselblad Vic,Peterson John L.,Wijns William,Parhizgar Azin,Kereiakes Dean J.,Krucoff Mitchell W.
Subject
Cardiology and Cardiovascular Medicine
Reference27 articles.
1. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis;Holmes;Circulation,2004
2. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial;Stone;Circulation,2004
3. Rao SV, Califf RM, Kramer JM, Peterson ED, Gross TP, Pepine CJ, Williams DO, Donohoe D, Waksman R, Krucoff MW. Post-market evaluation of breakthrough technologies. J Am Coll Cardiol [in press].
4. Surrogates, substudies, and real clinical end points in trials of drug-eluting stents;Kereiakes;J Am Coll Cardiol,2005
5. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents;Pfisterer;J Am Coll Cardiol,2006
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献